Microsoft Q1 2025 earnings preview. Analysts expect strong Azure growth and profitability improvements. Get the latest forecasts and trading insights.

Microsoft is encouraging people to talk to their laptops with new AI updates to Windows 11. But millions of computer users are still using Windows 10 as Microsoft ends free security support this week for the older operating system.

Microsoft Corporation (NASDAQ:MSFT) is one of the 13 best Fortune 500 stocks to invest in now. As of October 22, 2025, the most recent analyst sentiment on Microsoft Corporation (NASDAQ:MSFT) remains broadly bullish,

If AI returns underwhelm, Microsoft can reduce Capex, freeing up significant cash flow for shareholder returns. Learn more about MSFT stock here.

Windows 11’s AI upgrade brings Copilot voice wake word, Vision worldwide, on-device Actions for files, Microsoft/Google connectors, and a staged rollout.

It doesn't help that many people are still peeved about the death of Windows 10 support this week. Unsurprisingly, the company stresses that "Hey, Copilot" is a purely opt-in feature that's buried in the Copilot app settings. (Of course, that can always change, especially if the company wants to juice AI engagement stats in a few years.)

Nvidia, Microsoft, and BlackRock Just Made a $40 Billion Bet on AI Infrastructure. Here's What It Means for Investors. Is AI infrastructure spending still in the early stages of a massive growth run?

Microsoft is bringing new and expanded AI features to Windows 11 — adding "Hey Copilot" voice activation, on-screen assistance, and experimental agentic tools as it tries to redefine the PC for the AI era.

Microsoft expanded its Dragon Copilot artificial intelligence clinical assistant to nurses, designing its ambient AI technology specifically for unique nursing workflows. | Microsoft expanded its Dragon Copilot AI clinical assistant to nurses,

Russia, China, Iran and North Korea are using artificial intelligence to improve their cyberattacks on U.S. companies, governments and individuals, according to new research from Microsoft.

With market caps in the trillions, these tech behemoths are establishing a growing presence in drug development. Here’s what they’re up to.